PYC Therapeutics reported AUD230.58M in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Pacific Edge NZD 1.02B 210.22M Dec/2025
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
Telix Pharmaceuticals AUD 587.41M 141.14M Jun/2024